Caricamento...
Is microfluidics the “assembly line” for CRISPR-Cas9 gene-editing?
Acclaimed as one of the biggest scientific breakthroughs, the technology of CRISPR has brought significant improvement in the biotechnological spectrum—from editing genetic defects in diseases for gene therapy to modifying organisms for the production of biofuels. Since its inception, the CRISPR-Cas...
Salvato in:
| Pubblicato in: | Biomicrofluidics |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AIP Publishing LLC
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7688342/ https://ncbi.nlm.nih.gov/pubmed/33262863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1063/5.0029846 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|